Pegasus Farmaco

Hyderabad, India Founded: 1995 • Age: 31 yrs Minicorn
Manufacturer of capsules, tablets, syrups, drops, ointments and injectables

About Pegasus Farmaco

Pegasus Farmaco is a Healthcare company based in Hyderabad (India) founded in 1995. Manufacturer of capsules, tablets, syrups, drops, ointments and injectables. Pegasus Farmaco has raised $87.48 thousand across 1 funding round from investors including Surender Vuthoori, Indira Vuthoori and Neeraja Beti. The company has 127 employees. Pegasus Farmaco was last valued at $1.46 million in March 2016. Its Indian entity Pegasus Farmaco (India) Private Limited reported revenue of β‚Ή33.13 Cr. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its competitors include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed competitors have raised funding.

Company details

Pegasus Farmaco was founded in 1995 and is based in Hyderabad, India. Operations focus on the pharmaceutical sector, where capsules, tablets, syrups, drops, ointments, and injectables are produced across therapeutic categories such as antibiotics, analgesics, antipyretics, and muscle relaxants. Manufacturing facilities are certified under WHO-GMP standards and ISO 9001:2008, ensuring compliance with quality requirements.

  • Headquarters Hyderabad, India
  • Employees 127
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website pegasusfarmaco.com
  • Social LinkedIn
  • Legal Name Pegasus Farmaco (India) Private Limited
  • Date of Incorporation 18 Oct, 1995
  • Jurisdiction Telangana, India
Key Metrics
  • Annual Revenue
    ₹33.13 Cr

    FY 2021 · -34% YoY

  • Net Profit
    ₹51.2 Lakh

    FY 2021 · 2% margin

  • EBITDA
    ₹3.93 Cr

    FY 2021 · 12% margin

  • Total Equity Funding
    $87.48K (USD)

    in 1 rounds

  • Latest Funding Round
    $87.48K (USD), Angel Round

    Mar 2016

  • Employee Count
    127

Funding Insights of Pegasus Farmaco

Pegasus Farmaco has successfully raised a total of $87.48K through 1 strategic funding round. The most recent funding activity was a Angel Round of $87.48 thousand completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $87,481
  • Total Rounds 1
  • Last Round Angel Round β€” $87,481
  • First Round $87,481

    (Mar 2016)

  • Investors Count 4

All 1 funding rounds of Pegasus Farmaco with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2016$87,481Angel Round$1.46MSurender Vuthoori, Indira Vuthoori
Valuation history
DateValuationStage
Mar 2016$1.46Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $1.46M (Mar 2016). 4 investors in total: 0 institutional and 4 angel.

Investors in Pegasus Farmaco

Pegasus Farmaco has secured backing from 4 investors, including angel investors. Prominent investors backing the company include Surender Vuthoori, Indira Vuthoori and Neeraja Beti.

All
Angel
InvestorDescriptionFounded YearDomainLocation

Surender Vuthoori

unknown_6c814b35a53f46698

Indira Vuthoori

unknown_3a3c77cf2c07400b9

Neeraja Beti

unknown_76768e7d9e2e40aaa

Raghuveer Beti

Angel investor and tech entrepreneur, focused on early-stage Indian startups.
unknown_e1913f5195e74dad8
Premium access

Investor details for Pegasus Farmaco

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Pegasus Farmaco (India) Private Limited (Pegasus Farmaco)

Pegasus Farmaco (India) Private Limited is the primary company behind Pegasus Farmaco. The board of Pegasus Farmaco (India) Private Limited currently have 2 directors; the longest-serving is Raghuveer Beti, appointed in 2004. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Raghuveer Beti
DIN 00941702
Managing Director12 Apr 200422 yrs 7 moPegasus Farmaco (India) Private Limited
Neeraja Beti
DIN 00942957
Director30 Sep 200422 yrs 1 moPegasus Farmaco (India) Private Limited

Financials of Pegasus Farmaco

Figures of Pegasus Farmaco (India) Private Limited, the primary company behind Pegasus Farmaco, for FY 2021. Revenue was ₹33.13 Cr (-34% year on year). Net profit was ₹51.2 Lakh (2% margin). EBITDA was ₹3.93 Cr (12% margin). Revenue has grown at a compounded annual rate of -7% over three years and -13% over five years.

  • ₹33.13 CrRevenue · FY 2021 · -34% YoY
  • ₹51.2 LakhNet profit · 2% margin
  • ₹3.93 CrEBITDA · 12% margin
  • ₹4.47 CrPaid-up capital
  • 127Employees (provident fund records)
  • -7%Revenue CAGR, 3 years
  • -13%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Pegasus Farmaco (India) Private Limited are on its company page.

Premium access

Detailed financial statements for Pegasus Farmaco

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Pegasus Farmaco

3 dated milestones of Pegasus Farmaco across 21 years, from founding to its latest funding, stage changes and deals.

  1. Founded Pegasus Farmaco is founded.
  2. Funding First funding round of $87K.
  3. Milestone Reaches Minicorn status.

Competitors of Pegasus Farmaco

Pegasus Farmaco has 3 listed competitors in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India
Company offering a suite of R&D and manufacturing services for small molecules and generics
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed competitors of Pegasus Farmaco

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Pegasus Farmaco (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Pegasus Farmaco

Pegasus Farmaco was founded in 1995 and raised its 1st funding round 21 years after it was founded.

Pegasus Farmaco is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Pegasus Farmaco is a funded company, having raised a total of $87.48K across 1 funding round to date. The company's 1st funding round was a Angel Round of $87.48K, raised on Mar 2016.

Pegasus Farmaco has 127 employees.

The primary company behind Pegasus Farmaco, Pegasus Farmaco (India) Private Limited, reported revenue of β‚Ή33.13 Cr for FY 2021, down 34% year on year.

Pegasus Farmaco was founded in 1995 and is based in Hyderabad, India. Operations focus on the pharmaceutical sector, where capsules, tablets, syrups, drops, ointments, and injectables are produced across therapeutic categories such as antibiotics, analgesics, antipyretics, and muscle relaxants. Manufacturing facilities are certified under WHO-GMP standards and ISO 9001:2008, ensuring compliance with quality requirements.

Pegasus Farmaco's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Pegasus Farmaco has 4 investors. Key investors include Surender Vuthoori, Indira Vuthoori, Neeraja Beti, and Raghuveer Beti.

The valuation of Pegasus Farmaco is $1.46M as of Mar 2016.

Pegasus Farmaco operates through Pegasus Farmaco (India) Private Limited.

The legal entities of Pegasus Farmaco currently have 2 directors, including Neeraja Beti, Raghuveer Beti.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available